260 related articles for article (PubMed ID: 24201751)
1. Validation of C-reactive protein levels as a prognostic indicator for survival in a large cohort of pancreatic cancer patients.
Szkandera J; Stotz M; Absenger G; Stojakovic T; Samonigg H; Kornprat P; Schaberl-Moser R; Alzoughbi W; Lackner C; Ress AL; Seggewies FS; Gerger A; Hoefler G; Pichler M
Br J Cancer; 2014 Jan; 110(1):183-8. PubMed ID: 24201751
[TBL] [Abstract][Full Text] [Related]
2. Evaluation of uric acid as a prognostic blood-based marker in a large cohort of pancreatic cancer patients.
Stotz M; Szkandera J; Seidel J; Stojakovic T; Samonigg H; Reitz D; Gary T; Kornprat P; Schaberl-Moser R; Hoefler G; Gerger A; Pichler M
PLoS One; 2014; 9(8):e104730. PubMed ID: 25133546
[TBL] [Abstract][Full Text] [Related]
3. The elevated C-reactive protein level is associated with poor prognosis in prostate cancer patients treated with radiotherapy.
Thurner EM; Krenn-Pilko S; Langsenlehner U; Stojakovic T; Pichler M; Gerger A; Kapp KS; Langsenlehner T
Eur J Cancer; 2015 Mar; 51(5):610-9. PubMed ID: 25618827
[TBL] [Abstract][Full Text] [Related]
4. Prognostic value of neutrophil-lymphocyte ratio and level of C-reactive protein in a large cohort of pancreatic cancer patients: a retrospective study in a single institute in Japan.
Inoue D; Ozaka M; Matsuyama M; Yamada I; Takano K; Saiura A; Ishii H
Jpn J Clin Oncol; 2015 Jan; 45(1):61-6. PubMed ID: 25341546
[TBL] [Abstract][Full Text] [Related]
5. Increased neutrophil-lymphocyte ratio is a poor prognostic factor in patients with primary operable and inoperable pancreatic cancer.
Stotz M; Gerger A; Eisner F; Szkandera J; Loibner H; Ress AL; Kornprat P; AlZoughbi W; Seggewies FS; Lackner C; Stojakovic T; Samonigg H; Hoefler G; Pichler M
Br J Cancer; 2013 Jul; 109(2):416-21. PubMed ID: 23799847
[TBL] [Abstract][Full Text] [Related]
6. Validation of the prognostic relevance of plasma C-reactive protein levels in soft-tissue sarcoma patients.
Szkandera J; Gerger A; Liegl-Atzwanger B; Absenger G; Stotz M; Samonigg H; Maurer-Ertl W; Stojakovic T; Ploner F; Leithner A; Pichler M
Br J Cancer; 2013 Oct; 109(9):2316-22. PubMed ID: 24084772
[TBL] [Abstract][Full Text] [Related]
7. The lymphocyte to monocyte ratio in peripheral blood represents a novel prognostic marker in patients with pancreatic cancer.
Stotz M; Szkandera J; Stojakovic T; Seidel J; Samonigg H; Kornprat P; Schaberl-Moser R; Seggewies F; Hoefler G; Gerger A; Pichler M
Clin Chem Lab Med; 2015 Feb; 53(3):499-506. PubMed ID: 25389993
[TBL] [Abstract][Full Text] [Related]
8. Preoperative serum C-reactive protein levels and post-operative lymph node ratio are important predictors of survival after pancreaticoduodenectomy for pancreatic ductal adenocarcinoma.
Sanjay P; de Figueiredo RS; Leaver H; Ogston S; Kulli C; Polignano FM; Tait IS
JOP; 2012 Mar; 13(2):199-204. PubMed ID: 22406601
[TBL] [Abstract][Full Text] [Related]
9. Elevated amylase in plasma represents an adverse prognostic marker in patients with metastatic pancreatic cancer : A retrospective analysis.
Asamer E; Szkandera J; Gibiser P; Lembeck AL; Stojakovic T; Kornprat P; Lackner C; Winder T; Schlick K; Stöger H; Gerger A; Pichler M; Stotz M
Wien Klin Wochenschr; 2018 Oct; 130(19-20):569-574. PubMed ID: 30132196
[TBL] [Abstract][Full Text] [Related]
10. Clinico-pathological characteristics and clinical outcome of different histological types of pancreatic cancer in a large Middle European series.
Stotz M; Eisner F; Szkandera J; Absenger G; Kornprat P; Lackner C; Samonigg H; Gerger A; Pichler M
J Clin Pathol; 2013 Sep; 66(9):753-7. PubMed ID: 23750038
[TBL] [Abstract][Full Text] [Related]
11. External validation of the derived neutrophil to lymphocyte ratio as a prognostic marker on a large cohort of pancreatic cancer patients.
Szkandera J; Stotz M; Eisner F; Absenger G; Stojakovic T; Samonigg H; Kornprat P; Schaberl-Moser R; Alzoughbi W; Ress AL; Seggewies FS; Gerger A; Hoefler G; Pichler M
PLoS One; 2013; 8(11):e78225. PubMed ID: 24223776
[TBL] [Abstract][Full Text] [Related]
12. The prognostic value of the preoperative c-reactive protein/albumin ratio in ovarian cancer.
Liu Y; Chen S; Zheng C; Ding M; Zhang L; Wang L; Xie M; Zhou J
BMC Cancer; 2017 Apr; 17(1):285. PubMed ID: 28431566
[TBL] [Abstract][Full Text] [Related]
13. Validation of the pretreatment neutrophil-lymphocyte ratio as a predictor of overall survival in a cohort of patients with pancreatic ductal adenocarcinoma.
Ben Q; An W; Wang L; Wang W; Yu L; Yuan Y
Pancreas; 2015 Apr; 44(3):471-7. PubMed ID: 25423560
[TBL] [Abstract][Full Text] [Related]
14. C-reactive protein level is a prognostic indicator for survival and improves the predictive ability of the R-IPI score in diffuse large B-cell lymphoma patients.
Troppan KT; Schlick K; Deutsch A; Melchardt T; Egle A; Stojakovic T; Beham-Schmid C; Weiss L; Neureiter D; Wenzl K; Greil R; Neumeister P; Pichler M
Br J Cancer; 2014 Jul; 111(1):55-60. PubMed ID: 24874478
[TBL] [Abstract][Full Text] [Related]
15. C-Reactive Protein Level Is an Indicator of the Aggressiveness of Advanced Pancreatic Cancer.
Mitsunaga S; Ikeda M; Shimizu S; Ohno I; Takahashi H; Okuyama H; Ueno H; Morizane C; Kondo S; Sakamoto Y; Okusaka T; Ochiai A
Pancreas; 2016 Jan; 45(1):110-6. PubMed ID: 26566216
[TBL] [Abstract][Full Text] [Related]
16. Changes in CRP and CA19-9 during Preoperative Oncological Therapy Predict Postoperative Survival in Pancreatic Ductal Adenocarcinoma.
Nurmi AM; Mustonen H; Haglund C; Seppänen H
Oncology; 2021; 99(11):686-698. PubMed ID: 34412062
[TBL] [Abstract][Full Text] [Related]
17. The glasgow prognostic score as a predictor of survival in patients with potentially resectable pancreatic adenocarcinoma.
La Torre M; Nigri G; Cavallini M; Mercantini P; Ziparo V; Ramacciato G
Ann Surg Oncol; 2012 Sep; 19(9):2917-23. PubMed ID: 22488099
[TBL] [Abstract][Full Text] [Related]
18. Clinical usefulness of postoperative C-reactive protein/albumin ratio in pancreatic ductal adenocarcinoma.
Arima K; Yamashita YI; Hashimoto D; Nakagawa S; Umezaki N; Yamao T; Tsukamoto M; Kitano Y; Yamamura K; Miyata T; Okabe H; Ishimoto T; Imai K; Chikamoto A; Baba H
Am J Surg; 2018 Jul; 216(1):111-115. PubMed ID: 28859917
[TBL] [Abstract][Full Text] [Related]
19. Prognostic value of CA 19-9, CEA, CRP, LDH and bilirubin levels in locally advanced and metastatic pancreatic cancer: results from a multicenter, pooled analysis of patients receiving palliative chemotherapy.
Haas M; Heinemann V; Kullmann F; Laubender RP; Klose C; Bruns CJ; Holdenrieder S; Modest DP; Schulz C; Boeck S
J Cancer Res Clin Oncol; 2013 Apr; 139(4):681-9. PubMed ID: 23315099
[TBL] [Abstract][Full Text] [Related]
20. Prognostic role of neutrophil-to-lymphocyte ratio in advanced pancreatic ductal adenocarcinoma: impact of baseline fluctuation and changes during chemotherapy.
Teo M; Mohd Sharial MS; McDonnell F; Conlon KC; Ridgway PF; McDermott RS
Tumori; 2013; 99(4):516-22. PubMed ID: 24326841
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
